Cargando…
Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya
BACKGROUND: The contraceptive vaginal ring (NuvaRing), one of the Multipurpose Prevention Technologies (MPT) products, is effective in preventing unintended pregnancies and may contribute to reducing the frequency of Bacterial Vaginosis (BV), which is a risk factor for HIV acquisition, transmission,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371177/ https://www.ncbi.nlm.nih.gov/pubmed/37503186 http://dx.doi.org/10.1101/2023.07.14.23292684 |
_version_ | 1785078099548831744 |
---|---|
author | Casmir, Edinah Wairimu, Njeri Kiptinness, Catherine Oluoch, Lynda Maina, Stephen Gakuo Walker, Kristina Wilbekin Mugo, Nelly Marrazzo, Jeanne Ngure, Kenneth |
author_facet | Casmir, Edinah Wairimu, Njeri Kiptinness, Catherine Oluoch, Lynda Maina, Stephen Gakuo Walker, Kristina Wilbekin Mugo, Nelly Marrazzo, Jeanne Ngure, Kenneth |
author_sort | Casmir, Edinah |
collection | PubMed |
description | BACKGROUND: The contraceptive vaginal ring (NuvaRing), one of the Multipurpose Prevention Technologies (MPT) products, is effective in preventing unintended pregnancies and may contribute to reducing the frequency of Bacterial Vaginosis (BV), which is a risk factor for HIV acquisition, transmission, and shedding among women. NuvaRing may cause irregular menstruation, including menstrual suppression, which may influence women’s decision on product choice, use, and acceptability. In this prospective cohort study, we assessed women’s experiences with menstruation suppression following continued NuvaRing use. METHODS: A total of 18 in-depth interviews were conducted using a semi-structured interview guide among purposively selected women with BV in Thika, Kenya, aged 18–40 years, who used NuvaRing continuously. All women received counseling on possibility of menstrual suppression following continuous NuvaRing use. Audio recordings were transcribed verbatim and thematically analyzed. RESULTS: Participants who expected and were aware that menstrual suppression was a possible side effect of Nuvaring accepted its benefits, and expressed acceptance and desire to continue using NuvaRing. Participants who had not anticipated menstrual suppression expressed anxiety and fear, with some expressing desire to continue using NuvaRing but worried about unintended negative consequences. The ability to perform daily activities uninterrupted, reduced expenses on sanitary supplies, enhanced sexual pleasure and relationships, and absence of menstrual pain were benefits of menstrual suppression. Although all participants received counseling on menstrual suppression, some expressed anxiety over the possibility of unintended pregnancy. As a result, they frequented medical facilities for health check-ups and pregnancy tests, and some used combined oral contraceptives to induce menses. CONCLUSION: Understanding perceptions regarding menstrual suppression is crucial in offering targeted and comprehensive counseling to improve women’s understanding of menstruation suppression to influence acceptance and use of NuvaRing. Additionally, improved male involvement in reproductive health concerns and women’s autonomy in discussing reproductive health issues with partners is essential. |
format | Online Article Text |
id | pubmed-10371177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-103711772023-07-27 Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya Casmir, Edinah Wairimu, Njeri Kiptinness, Catherine Oluoch, Lynda Maina, Stephen Gakuo Walker, Kristina Wilbekin Mugo, Nelly Marrazzo, Jeanne Ngure, Kenneth medRxiv Article BACKGROUND: The contraceptive vaginal ring (NuvaRing), one of the Multipurpose Prevention Technologies (MPT) products, is effective in preventing unintended pregnancies and may contribute to reducing the frequency of Bacterial Vaginosis (BV), which is a risk factor for HIV acquisition, transmission, and shedding among women. NuvaRing may cause irregular menstruation, including menstrual suppression, which may influence women’s decision on product choice, use, and acceptability. In this prospective cohort study, we assessed women’s experiences with menstruation suppression following continued NuvaRing use. METHODS: A total of 18 in-depth interviews were conducted using a semi-structured interview guide among purposively selected women with BV in Thika, Kenya, aged 18–40 years, who used NuvaRing continuously. All women received counseling on possibility of menstrual suppression following continuous NuvaRing use. Audio recordings were transcribed verbatim and thematically analyzed. RESULTS: Participants who expected and were aware that menstrual suppression was a possible side effect of Nuvaring accepted its benefits, and expressed acceptance and desire to continue using NuvaRing. Participants who had not anticipated menstrual suppression expressed anxiety and fear, with some expressing desire to continue using NuvaRing but worried about unintended negative consequences. The ability to perform daily activities uninterrupted, reduced expenses on sanitary supplies, enhanced sexual pleasure and relationships, and absence of menstrual pain were benefits of menstrual suppression. Although all participants received counseling on menstrual suppression, some expressed anxiety over the possibility of unintended pregnancy. As a result, they frequented medical facilities for health check-ups and pregnancy tests, and some used combined oral contraceptives to induce menses. CONCLUSION: Understanding perceptions regarding menstrual suppression is crucial in offering targeted and comprehensive counseling to improve women’s understanding of menstruation suppression to influence acceptance and use of NuvaRing. Additionally, improved male involvement in reproductive health concerns and women’s autonomy in discussing reproductive health issues with partners is essential. Cold Spring Harbor Laboratory 2023-07-16 /pmc/articles/PMC10371177/ /pubmed/37503186 http://dx.doi.org/10.1101/2023.07.14.23292684 Text en This article is a US Government work. |
spellingShingle | Article Casmir, Edinah Wairimu, Njeri Kiptinness, Catherine Oluoch, Lynda Maina, Stephen Gakuo Walker, Kristina Wilbekin Mugo, Nelly Marrazzo, Jeanne Ngure, Kenneth Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya |
title | Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya |
title_full | Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya |
title_fullStr | Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya |
title_full_unstemmed | Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya |
title_short | Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya |
title_sort | experiences and attitudes towards menstrual suppression among women with bacterial vaginosis randomised to continuous use of nuvaring in kenya |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371177/ https://www.ncbi.nlm.nih.gov/pubmed/37503186 http://dx.doi.org/10.1101/2023.07.14.23292684 |
work_keys_str_mv | AT casmiredinah experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya AT wairimunjeri experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya AT kiptinnesscatherine experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya AT oluochlynda experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya AT mainastephengakuo experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya AT walkerkristinawilbekin experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya AT mugonelly experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya AT marrazzojeanne experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya AT ngurekenneth experiencesandattitudestowardsmenstrualsuppressionamongwomenwithbacterialvaginosisrandomisedtocontinuoususeofnuvaringinkenya |